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ABSTRACT: 
In this communication, the application of a previously developed combined asymmetric PCR-
magnetic disposable amperometric genosensor to the determination of Streptococ-cus pneumoniae 
in clinical samples is reported. Results obtained with the amperometric magnetogenosensor assay 
and the gold standard protocol used (standard blood agar culture) for these tests have been 
compared through the analysis of 69 clinical samples and 126 agar plate cultures with suspicion 
of having S. pneumoniae. The quality of the devel-oped diagnostic test has been evaluated by 
constructing the corresponding Receiver Operating Characteristic (ROC) curves. Data provide a 
sensitivity of 90.30% and a specificity of 76.47 %, allowing unequivocal discrimination of the target 
bacteria from S. mitis and other closely related species. The aPCR disposable magnetogenosensor 
provides the results in only 5 h in comparison with the classical optochin identification test which 
requires up to 48 h.
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1. Introduction
The worldwide rise of  antibiotic-resistant 
Streptococcus pneumoniae has fostered the 
development of  methods for the accurate and 
rapid identification of  pneumococci. Gram 
staining and optochin susceptibility are most 
frequently employed in the clinical setting 
al-though bacterial culture requires several 
days to complete [1]. In addition, the prior 
ad-ministration of  antimicrobials reduces the 
possibility to accurately identify the pathogen. 
Immunochromatographic methods such as Binax 
NOW [2] have been developed in the last years for 
pathogen identification. Unfortunately, most of 
these methods, albeit providing rapid results, lack 
of satisfactory specificity and sensitivity. Besides, 
PCR amplification of  pneumococcus-specific 
genes usually demands complicated processes 
and are not yet widely available in clinical labo-
ratories.
The S. pneumoniae lytA gene encodes the major 
autolysin that has been considered unique gene 
to this species [3]. Although pneumococcal (and 
some streptococcal) temperate phages together 
with Streptococcus pseudopneumoniae harbor lytA 
homologs, the existence of characteristic signatures 
in this gene has allowed us to design specific 
oligonucleotide primers to accurately distinguish 
“true” pneumococci from either prophages or no 
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(SMG). An amperometric magnetogenosensor 
has been recently developed [4]. As a proof of 
concept, this method has shown that it is possible 
to discriminate between noninoculated blood and 
urine samples and samples inoculated with only 
103 CFU mL−1 S. pneumoniae.
The present communication discusses the re-
sults obtained with the lytA genosensor using a 
variety of clinical samples, and the advantages 
of this procedure in the rapid identification of S. 
pneumoniae.
2. Experimental Section
2.1.. Apparatus and electrodes
Amperometric measurements were carried out 
with a single-channel amperometric detector 
purchased from InBea Biosensores S. L. (Madrid, 
Spain). A P-Selecta (Scharlab) ultrasonic bath, 
a PCR cabinet Biosan DNA/RNA UV-cleaner 
UVC/T−M−AR, a Thermomixer MT100 
constant temperature incubator shaker (Universal 
Labortechnik), and a P-Selecta Agimatic magnetic 
stirrer, were also used. Gold screen-printed elec-
trodes (220AT, 4-mm∅, Au/SPEs) purchased 
from Dropsens were employed. The format 
of  these electrodes includes a silver pseudo-
reference electrode and a gold counter electrode. 
A neodymium magnet (AIMAN GZ) was used 
to control the attraction of the modified magnetic 
beads (MBs) to the Au/SPEs surfaces. Magnetic 
separation steps for incubation/washing processes 
were performed using a Dynal MPC-S (product 
No. 120.20, Dynal Biotech ASA, Norway) mag-
netic particle concentrator. All PCR experiments 
were conducted in a Mygene series Peltier thermal 
cycler model NGN96G. 
2.2. Reagents and solutions
Streptavidin-modified MBs (10 mg mL−1) 
(Dynabeads M-280 Streptavidin) were pur-
chased from Dynal Biotech ASA. Strep-
tavidin-horseradish peroxidase (HRP) polymer, 
ultrasensitive was purchased from Sigma and used 
as recommended. Stock so-lutions of streptavidin-
HRP (10 μg mL−1) were prepared in phosphate 
buffered saline (PBS; 10-mM sodium phosphate 
buffer, pH 7.4 containing 138 mM NaCl, and 2.7 
mM KCl) supplemented with 0.05% (v/v) Tween-20 
(PBST). TMB-H2O2-K-Blue reagent solution from 
Neogen in a ready-to-use reagent format (K-Blue 
enhanced-activity substrate, also containing 
H2O2) was also used as enzymatic substrate. The 
oligonucleotides used in this work were synthesized 
by Sigma Genosys, and are listed in Table 1.
B&W buffer solution (10 mM Tris–HCl, pH 7.5; 
1 mM EDTA, 2 M NaCl) was used to prepare the 
biotinylated probe to be immobilized at the MBs. 
All chemicals used were of  analytical-reagent 
grade, and deionized water was obtained from a 
Millipore Milli-Q purification system (18.2 MΩ 
cm).
Table 1: Oligonucleotides used in this study 
2.3. Samples and DNA isolation
A preclinical comparison between the results 
achieved with the amperometric magneto-
genosensor assay and the gold standard protocol 
(standard blood agar culture) was conducted by 
analyzing 69 clinical samples and 126 agar plate 
cultures with suspicion of having S. pneumoniae.
Analyzed clinical isolates (sputum, pus, blood, 
throat swab, bronchial, nasal and tracheal 
aspirates, eye, conjunctive swab, alveolar washes, 
skin, pleural fluid, and abscess) were collected 
from La Paz Hospital (Ma-drid, Spain) patients.
Magnetoimmunosensor determinations were 
performed using DNA extracted from both kinds 
of samples with the UltraClean® Microbial DNA 
isolation kit (MO BIO, Carlsbad, CA USA) 
according to the manufacturer´s instructions. 
The extracted DNA was stored at −20 °C until 
use. It is worth to mention that for the analysis 
of the clinical samples, no other pretreatment was 

















The quality of the developed diagnostic test was 
evaluated by constructing the corre-sponding 
ROC curves, performing the statistical analysis 
with SPSS v. 17.0 software. 
2.4. Asymmetric PCR amplification
The asymmetric PCR (aPCR) reaction mix-
ture (50 μL) contained 4 μL or 2 μL (for clinical 
samples and agar plate cultures, respectively) of 
the extracted DNA, 1 μL of a 5 μM forward primer 
solution, 8 μL of  a 5 μM reverse biotinylated 
primer solution, and other components following 
the protocol for PCR with Taq DNA polymerase. 
The PCR conditions were: denaturation at 94 °C 
for 4 min, followed by 35 cycles of 94 °C for 1 min 
(denaturation), 60 °C for 1 min (annealing), 72 °C 
for 1 min (extension), and 3 min final extension. 
During the process, the lower concentrated 
forward primer acted as a limiting primer and 
target dsDNA fragments were produced when 
both primers were present in the PCR mixture. 
However, after the limiting primer was consumed 
the remaining primer (biotinylated reverse primer) 
continued to amplify the target DNA, which 
resulted in the PCR products predominantly being 
biotinylated ss lytA gene fragments. 
2.5. Magnetic beads modification
For the MBs modification, 10 μL of  strep-
tavidin-coated MBs were transferred to a 1.5 
mL centrifuge tube, washed twice with 100 
μL of  B&W buffer and resuspended in 100 
μL of the same buffer containing 100 pmol of 
the biotinylated probe (Fig. 1). The probe was 
captured onto the beads for 50 min at 37 °C with 
gentle mixing (600 rpm). Subsequently, the probe 
modified MBs were washed twice with 100 μL 
of Tris–HCl buffer (pH 7.2) and resuspended in 
100 μL of the same buffer containing the desired 
amount of biotinylated target (or 2 times di-luted 
aPCR mixture). The reaction was left to proceed 
for 50 min at 37 °C under stirring (600 rpm). The 
hybrid-attached beads were washed twice with 500 
μL of Tris–HCl (pH 7.2). At this time, labeling of 
the target with the streptavidin-HRP polymer 
enzyme was achieved. Enzyme tag took place by 
adding 100 μL of 10 μg mL−1 streptavidin-HRP 
polymer solution prepared in PBST. The labeling 
procedure was left to proceed for 60 min at 37 °C 
with gentle mixing (600 rpm). The enzyme-tagged 
DNA beads assembly was then washed five times 
(2 min each) with 500 μL of  PBST, and once 
more with 500 μL of PBS. MBs were finally resus-
pended in 45 μL of PBS.
Fig. 1: Schematic representation of the MBs-modification 
(a) and detection (b) steps carried out.
2.6. Amperometric measurements
Amperometric measurements were carried out 
by placing the 45-μL drop of the modified MBs 
suspension onto the Au/SPEs surface, covering 
the three electrodes area. When a steady-state 
current was obtained, at an applied potential of 
–0.10 V vs the Ag pseudo-reference electrode, 5 
µL of the TMB-H2O2 solution were deposited 
on the working electrode surface and the current 
signal used for analytical purposes was read 200 s 
afterward.
3. Results and Discussion
Amperometric measurements were performed for 
both, the samples and the corresponding PCR 
blanks, and thus, sample signals were normalized 
by using the blank signal. For the streptococcal 
cultures, samples were classified in two categories: 
S. pneumoniae vs. non-pneumoniae Streptococcus 
sp. based on the standard microbiological 
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amperometric measurements were compared with 
the identification analyses using a ROC curve 
analysis. 
Using a cutoff value of 1.9 for the sample to blank 
ratio (ratio>1.9 meaning that the sample is S. 
pneumoniae) a sensitivity of 83.5 % and specificity 
of 72.4 % were obtained (Table 2).






+ 81 8 89
− 16 21 37
97 29 126
(+: positive sample; −: negative sample)
Concerning the clinical samples, the classifi-
cation in the same two categories was based on 
the microbiological identification and the clinical 
relevance assigned by a clinical microbiologist: S. 
pneumoniae vs. S. pneumoniae negative samples. 
This last category includes sterile samples, 
samples containing a major non-pneumoniae 
Streptococcus sp. or other pathogens, and samples 
that may contain small amounts of S. pneumoniae 
but not considered clinically relevant (i.e. part of 
the saprophytic flora). The ROC analysis indi-
cated that the best cutoff for the sample to blank 
ratio is 1.3 (ratio>1.3 meaning that the sample is 
clinically relevant S. pneumoniae). For this cutoff  
the sensitivity was 90.3 % and the specificity was 
76.4 % (Table 3).






+ 47 4 51
− 5 13 18
52 17 69
(+: positive sample; −: negative sample)
It should be noted that some samples gave a 
positive result with the magnetogenosensor 
and a negative one through microbial identi-
fication. Current studies are aimed at discerning 
if  this can be attributed to an inhibition of the 
bacterial growing caused by antibiotics, the lower 
bacterial content being only detected by the 
magnetogenosensor. 
4. Conclusion
The results achieved in the clinical validation 
of this new strategy based on the use of a novel 
amperometric magnetogenosensor are highly 
promising taking into account the complexity 
and variability between the analyzed samples and 
the simplicity and the short response time of the 
implemented methodology. The combined a-PCR-
magnetic disposable genosensor approach exhibits 
relevant analytical advantages with respect to 
other S. pneumoniae detection methods previously 
reported, allowing an unequivocal discrimination 
of  the target bacteria from S. mitis and other 
closely related pneumococcal species (such as 
other streptococci of the mitis group, SMG) and 
providing results in only 5 h, in comparison with 
the classical optochin identification test which 
requires 48 h.
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